Maj, D., Zarba, M., Wells, C., Chehade, R. E. H., Ozay, Z. I., Pal, S. K., Beuselinck, B., Liow, E. C. H., Alva, A. S., Powles, T., Bjarnason, G. A., Wood, L., Kanesvaran, R., Velasco, G. D., Lee, J. L., Templeton, A. J., McKay, R. R., Suarez, C., Choueiri, T. K., Heng, D. Y. C. (2025). Real-world outcomes of first-line dual immunotherapy versus combination VEGF immunotherapy in intermediate-poor risk metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Data Consortium (IMDC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.477